ME/NaPhos/MB/Hyo1 and Mogamulizumab
Determining the interaction of ME/NaPhos/MB/Hyo1 and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- ME/NaPhos/MB/Hyo1-Mogamulizumab-kpkc
- ME/NaPhos/MB/Hyo1-Mogamulizumab-kpkc Intravenous
- ME/NaPhos/MB/Hyo1-Molindone
- ME/NaPhos/MB/Hyo1-Mometasone (Oral Inhalation)
- ME/NaPhos/MB/Hyo1-Mometasone and Formoterol
- ME/NaPhos/MB/Hyo1-Mometasone and formoterol Inhalation
- Mogamulizumab-Measles and rubella virus vaccine live Intramuscular, Injection
- Mogamulizumab-Measles virus vaccine, live Subcutaneous
- Mogamulizumab-Measles, mumps, and rubella (MMR) vaccine
- Mogamulizumab-Measles, Mumps, and Rubella Vaccine
- Mogamulizumab-Measles, Mumps, and Rubella Virus Vaccine
- Mogamulizumab-Measles, mumps, and rubella virus vaccine live Subcutaneous, Intramuscular